EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO
Glasgow, Scotland – 1 February 2024. EnteroBiotix Limited (“EBX”), a clinical stage biopharmaceutical company with the premier platform for full-spectrum microbiome therapeutics, today announced the appointments of Dr James Barnes as Chief Operating Officer (“COO”) and Chris Lea as Chief Financial Officer (“CFO”).
